FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2076010693> ?p ?o ?g. }

• W2076010693 endingPage "130" @default.
• W2076010693 startingPage "109" @default.
• W2076010693 abstract "To explore further the varied clinical expression of anti-Ro(SS-A) antibody positive patients and to determine the outcomes of these patients, we followed 100 anti-Ro(SS-A) antibody positive patients, originally seen at the Johns Hopkins Medical Institutions in 1982 and 1983, over a 10-year period. The results of this study indicate that anti-Ro(SS-A) antibody positive patients have a diverse clinical presentation and that the anti-Ro(SS-A) antibody response generally persists for years. Some of these patients appear to have a static disease process for years. However, 65% (51, including 13 deaths, of 78 patients) of the patients for whom we had follow-up data had a chronic (10 years or greater) progressive disease process. Black patients, in general, have an earlier onset of disease and may have a more severe disease than white patients. At least 25% of our anti-Ro(SS-A) antibody positive patients demonstrated a dynamic change in clinical presentation with the development of Sjögren syndrome and/or a progressive rheumatoid-like arthritis. Interstitial pulmonary disease, central nervous system disease, and vasculitic insults occur frequently in these patients. Renal disease occurred in 19 anti-Ro(SS-A) positive patients, and in 47% of these renal disease patients, no anti-DNA antibodies (dsDNA or ssDNA) were detected. Cutaneous manifestations are prominent in anti-Ro(SS-A) antibody positive patients with lupus. Photosensitivity and a malar dermatitis were the most common features. Twenty percent of lupus patients had discoid lesions, and 20% had SCLE lesions. Based on this study, we believe that anti-Ro(SS-A) antibody positive patients should be routinely evaluated for the emergence of systemic features. Since these systemic features are at least in part, if not solely, the result of inflammation, early treatment with steroids and/or immunosuppressive agents may minimize the damage and influence in a positive manner the significant morbidity and mortality observed in some anti-Ro(SS-A) antibody positive patients." @default.
• W2076010693 created "2016-06-24" @default.
• W2076010693 creator A5016157822 @default.
• W2076010693 creator A5022671307 @default.
• W2076010693 creator A5026165132 @default.
• W2076010693 creator A5030849116 @default.
• W2076010693 creator A5031014816 @default.
• W2076010693 creator A5067563830 @default.
• W2076010693 creator A5082713013 @default.
• W2076010693 creator A5088651064 @default.
• W2076010693 date "1995-05-01" @default.
• W2076010693 modified "2023-10-18" @default.
• W2076010693 title "One Hundred Anti-Ro (SS-A) Antibody Positive Patients: A 10-Year Follow-Up" @default.
• W2076010693 cites W1236342233 @default.
• W2076010693 cites W1559508155 @default.
• W2076010693 cites W1966000146 @default.
• W2076010693 cites W1969716168 @default.
• W2076010693 cites W1983649543 @default.
• W2076010693 cites W1991238351 @default.
• W2076010693 cites W1991830280 @default.
• W2076010693 cites W1995321898 @default.
• W2076010693 cites W1996631006 @default.
• W2076010693 cites W1998633845 @default.
• W2076010693 cites W1998703130 @default.
• W2076010693 cites W1998901639 @default.
• W2076010693 cites W1999174401 @default.
• W2076010693 cites W2001298478 @default.
• W2076010693 cites W2004989086 @default.
• W2076010693 cites W2005336388 @default.
• W2076010693 cites W2011283239 @default.
• W2076010693 cites W2012552244 @default.
• W2076010693 cites W2014356691 @default.
• W2076010693 cites W2015265853 @default.
• W2076010693 cites W2020036607 @default.
• W2076010693 cites W2020927386 @default.
• W2076010693 cites W2028949050 @default.
• W2076010693 cites W2048375132 @default.
• W2076010693 cites W2049901248 @default.
• W2076010693 cites W2058336420 @default.
• W2076010693 cites W2063138417 @default.
• W2076010693 cites W2066525386 @default.
• W2076010693 cites W2071155648 @default.
• W2076010693 cites W2071585782 @default.
• W2076010693 cites W2082314813 @default.
• W2076010693 cites W2084547432 @default.
• W2076010693 cites W2091484618 @default.
• W2076010693 cites W2092016578 @default.
• W2076010693 cites W2092550229 @default.
• W2076010693 cites W2115037381 @default.
• W2076010693 cites W2120047466 @default.
• W2076010693 cites W2146203649 @default.
• W2076010693 cites W2147080689 @default.
• W2076010693 cites W2152348310 @default.
• W2076010693 cites W2158671914 @default.
• W2076010693 cites W2336893887 @default.
• W2076010693 cites W2397266140 @default.
• W2076010693 cites W2437161967 @default.
• W2076010693 cites W4245764286 @default.
• W2076010693 cites W4249807762 @default.
• W2076010693 cites W4250212532 @default.
• W2076010693 cites W4252324895 @default.
• W2076010693 cites W4255623771 @default.
• W2076010693 cites W4298229265 @default.
• W2076010693 doi "https://doi.org/10.1097/00005792-199505000-00001" @default.
• W2076010693 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7760718" @default.
• W2076010693 hasPublicationYear "1995" @default.
• W2076010693 type Work @default.
• W2076010693 sameAs 2076010693 @default.
• W2076010693 citedByCount "99" @default.
• W2076010693 countsByYear W20760106932012 @default.
• W2076010693 countsByYear W20760106932013 @default.
• W2076010693 countsByYear W20760106932015 @default.
• W2076010693 countsByYear W20760106932018 @default.
• W2076010693 countsByYear W20760106932020 @default.
• W2076010693 countsByYear W20760106932021 @default.
• W2076010693 countsByYear W20760106932022 @default.
• W2076010693 crossrefType "journal-article" @default.
• W2076010693 hasAuthorship W2076010693A5016157822 @default.
• W2076010693 hasAuthorship W2076010693A5022671307 @default.
• W2076010693 hasAuthorship W2076010693A5026165132 @default.
• W2076010693 hasAuthorship W2076010693A5030849116 @default.
• W2076010693 hasAuthorship W2076010693A5031014816 @default.
• W2076010693 hasAuthorship W2076010693A5067563830 @default.
• W2076010693 hasAuthorship W2076010693A5082713013 @default.
• W2076010693 hasAuthorship W2076010693A5088651064 @default.
• W2076010693 hasBestOaLocation W20760106931 @default.
• W2076010693 hasConcept C126322002 @default.
• W2076010693 hasConcept C159654299 @default.
• W2076010693 hasConcept C16005928 @default.
• W2076010693 hasConcept C203014093 @default.
• W2076010693 hasConcept C2776670291 @default.
• W2076010693 hasConcept C2777077863 @default.
• W2076010693 hasConcept C2777575956 @default.
• W2076010693 hasConcept C2779075594 @default.
• W2076010693 hasConcept C2779134260 @default.
• W2076010693 hasConcept C71924100 @default.
• W2076010693 hasConcept C90924648 @default.
• W2076010693 hasConceptScore W2076010693C126322002 @default.

• next